RESEARCH-USE BIOSIMILAR ANTIBODY

Birtamimab

Monoclonal antibody · IgG1

SAAIgG1RUO

Birtamimab (NEOD001) is an investigational monoclonal antibody that specifically and selectively target and clear the amyloid. Birtamimab can be used for the research of light chain amyloidosis.

TARGETSAA
YMonoclonal antibody
CATALOGSC-BS-713
CATALOG NUMBERSC-BS-713
MOLECULAR WEIGHTApprox. 146.44 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Birtamimab (NEOD001) is an investigational monoclonal antibody that specifically and selectively target and clear the amyloid. Birtamimab can be used for the research of light chain amyloidosis.

Birtamimab is a recombinant research-use antibody directed against SAA.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Birtamimab | StellaCyte